ABLYNX PRESENTS UNIQUE NANOBODY DRUG INHALATION TECHNOLOGY

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
ABLYNX PRESENTS UNIQUE NANOBODY DRUG INHALATION TECHNOLOGY AT THE RESPIRATORY DRUG DELIVERY EUROPE 2015 CONFERENCE

GHENT, Belgium, May 7, 2015 (GLOBE NEWSWIRE) -- Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] presented an overview of its unique and versatile Nanobody platform and its application for inhaled biological medication at the Respiratory Drug Delivery (RDD) Europe 2015 Conference (Nice, France, May 5-8). 

The presentation focused on Ablynx's wholly-owned, innovative, anti-RSV inhaled Nanobody therapeutic, ALX-0171, which is being developed for the treatment of established RSV infections in the general paediatric population.

In vitro studies [1] have demonstrated that ALX-0171 is potent and shows superior virus neutralisation. The robustness of the Nanobody also allows administration via inhalation, enabling delivery of ALX-0171 directly to the site of viral infection (i.e. the respiratory tract, including the lower airways) where it inhibits viral replication and neutralises viral activity by blocking virus uptake in the cells.

In vivo proof-of-concept with ALX-0171 has been achieved using a neonatal animal model, demonstrating that daily inhalation of the Nanobody for three consecutive days in animals with established infection, resulted in a marked reduction of symptoms of illness, viral titres and RSV-associated lung pathology. Clinically, ALX-0171 has been shown to be well tolerated in more than 100 adults, including subjects with sensitive (hyper-reactive) airways. 

In December 2014 , Ablynx initiated a first-in-infant Phase IIa study in the Northern Hemisphere to evaluate the safety, tolerability and clinical activity (including effect on feeding, respiratory rate, wheezing, coughing, general appearance and clinical scores) of inhaled ALX-0171 in otherwise healthy infants (aged 3-24 months) diagnosed with RSV and hospitalised for a lower respiratory tract infection. The lead-in part of the study with five infants has been successfully completed and recruitment is now on-going for the placebo-controlled part of the trial for which it is intended to recruit a total of 30 infants. Recruitment for this latter phase already started in the Northern Hemisphere but the RSV season has now finished there and preparations are currently on-going to open clinical study centres in the Asia-Pacific region where the RSV season occurs later in the calendar year. The goal is to complete recruitment by the end of 2015 with results expected during the first half of 2016.

The presentation at the RDD Conference has been made available on the Ablynx website under the section R&D portfolio .

Edwin Moses, Chief Executive Officer of Ablynx, said: "Ablynx is pioneering the development of a potentially first-in-class treatment for RSV, which we believe is an area of major unmet need, especially in infants. We are utilising the robustness of Nanobodies to deliver them via nebulisation, a technique which may be beneficial in other pulmonary diseases. ALX-0171 is one of our wholly-owned, lead proprietary programmes in clinical development which we are currently advancing internally."

About Respiratory Syncytial Virus

RSV remains the primary cause of infant hospitalisation and virus associated deaths in infants. In addition, RSV infections have been linked to an increased risk for asthma development later in life [2] . Current treatment of patients infected with RSV is primarily focussed on symptomatic relief, hence the need for an effective and specific anti-RSV therapeutic. It is estimated that there are more than 300,000 children (aged <5 years) hospitalised each year in the seven major pharmaceutical markets and the reported infection rate is 70-80% in children under two years of age [3] . In addition, RSV infection is a significant cause of pulmonary disease in transplant patients, immune-compromised subjects and the elderly.

About Ablynx

Ablynx is a biopharmaceutical company engaged in the development of Nanobodies® , proprietary therapeutic proteins based on single-domain antibody fragments, which combine the advantages of conventional antibody drugs with some of the features of small-molecule drugs. Ablynx is dedicated to creating new medicines which will make a real difference to society. Today, the Company has more than 30 proprietary and partnered programmes in development in various therapeutic areas including inflammation, haematology, oncology and respiratory disease. The Company has collaborations with multiple pharmaceutical companies including AbbVie, Boehringer Ingelheim, Eddingpharm, Merck & Co, Inc., Merck Serono and Novartis. The Company is headquartered in Ghent, Belgium. More information can be found on www.ablynx.com .

For more information, please contact Ablynx: Dr Edwin Moses CEO t:   +32 (0)9 262 00 07 m: +32 (0)473 39 50 68 e:  edwin.moses@ablynx.com

Marieke Vermeersch Associate Director Investor Relations t:   +32 (0)9 262 00 82 m: +32 (0)479 49 06 03 e:  marieke.vermeersch@ablynx.com

Ablynx media relations Consilium Strategic Communications: Mary-Jane Elliott, Jonathan Birt, Chris Welsh, Lindsey Neville t:   +44 203 709 5700 e : ablynx@consilium-comms.com

[1] Study results presented at the Human Antibodies and Hybridomas conference in 2014; presentation on Ablynx website [2] Sigurs et al , Thorax 2010; Backman et al , Acta Pediatr 2014

[3] Hall et al , NEJM, 2009; extrapolation based on estimated US prevalence

Pdf version of the press release http://hugin.info/137912/R/1919287/687129.pdf

HUG#1919287

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dario’s Second Women’s Health Win Tests Expansion Case

Updated Category News Views 89

Midlife care just became the newest proving ground for DarioHealth’s sales pitch. The company says The Minnesota Star Tribune has expanded its existing relationship to include Dario Women™, a program for employees navigating perimenopause and menopause. Eligible employees are expected to gain access in January 2027. For NASDAQ:DRIO, this is not some grand revenue...

Continue Reading
Hyster-Yale's $125 Million Convertible Debt Shuffle

Updated Category News Views 142

Forklifts do not make headlines often, but debt terms sure can. Hyster-Yale has proposed a $125 million private offering of convertible senior notes due November 15, 2031, with buyers able to take another $18.75 million if the initial purchasers exercise their option. For NYSE:HY holders, this is not a victory lap or a distress flare by itself. It is a refinancing...

Continue Reading
Housing's Value Equation Is Getting More Complicated

Updated Category News Views 91

A homeowner's insurance bill has become a louder market signal than a granite countertop. Green Builder Media's latest batch of research, publishing and events is aimed squarely at that uncomfortable truth: housing is no longer judged only by the price on the contract. Buyers, builders, lenders and insurers are being pushed to reckon with what a home costs to own, protect...

Continue Reading
Miami Office Puts Dubai Closer to U.S. Business Deal Flow

Updated Category News Views 11

Miami is not a random pin on a map; it is a deliberate front door to the Americas, and Dubai International Chamber has decided it needs someone standing in it. The chamber opened a representative office there on November 19, 2026, its second in the United States after launching in New York during the Dubai Business Forum – USA in November 2025. This is not the sort of...

Continue Reading
Thanksgiving Dog Safety Is a Pet Care Reality Check

Updated Category News Views 103

A crowded Thanksgiving kitchen can turn a well-behaved dog into a scavenger with lousy odds. Camp Bow Wow’s holiday guidance is not pretending the meal itself is the problem; the trouble is that a house full of distracted people, rich food and unsecured trash creates a pile of easy mistakes. For pet owners, that is a fair reminder. For anybody watching the pet-care...

Continue Reading
Happiest Minds Extends Absa Banking Platform Reach

Updated Category News Views 34

Mauritius just handed Happiest Minds a useful, if modest, banking-tech scorecard. On November 19, 2026, the company said its cloud-native Arttha platform had been deployed to support selected capabilities within Spark by Absa, a digital banking and lifestyle app from Absa Bank (Mauritius). This is not the sort of announcement that lets anybody pencil in a giant revenue...

Continue Reading
Marina del Rey's Travel Award Brings Fresh Attention

Updated Category News Views 86

A harbor town just got handed a useful little megaphone. On November 18, 2026, the Marina del Rey Tourism Board said Marina del Rey had been selected as a winner in Good Housekeeping's 2027 Travel Awards. That is not a quarterly earnings event, and nobody ought to dress it up as one. Still, in the visitor economy, recognition from a broad consumer publication can matter...

Continue Reading
Valley Family Health Breach Notice Raises Hard Questions

Updated Category News Views 68

Seven months is a long time for sensitive patient data to sit inside an unresolved security story. Valley Family Health Care, Inc. says it suffered a network disruption on or about March 13, 2026, investigated with outside cybersecurity specialists, and ultimately determined that an unauthorized actor accessed and acquired certain files. The formal notification process...

Continue Reading
CHN Energy's Indonesia Record Deserves a Hard Look

Updated Category News Views 5

Twenty years of boots sinking into swamp mud tells a sturdier story than a polished anniversary slogan. CHN Energy says it entered Indonesia's energy market two decades ago and has since built an operating presence around reliable electricity, local training and community work. In a country scattered across thousands of islands, dependable power is not some decorative...

Continue Reading
A €18 Million Mecca Chandelier Tests Austrian Craft

Updated Category News Views 229

Scale Is Easy to Boast About, Delivery Is Not A 34.1-metre chandelier hanging in Mecca is the sort of job that makes ordinary project talk sound downright silly. Lights of Vienna says it designed, built, tested, shipped and installed this monster for the Grand Mosque's Shamiya area, with a contract value of roughly €18 million. That is a serious piece of work for a...

Continue Reading

Top 5 Most Recently Viewed Articles

Stock Market Sees Notable Gains with Various Companies Rising

Updated Category News Views 165

U.S. Stocks Surge With Promising Developments The U.S. stock market experienced a significant uptick recently, highlighted by the Dow Jones index increasing over 200 points. This positive momentum was driven by various companies showcasing impressive stock gains during the trading day. Olo Inc.: A Leap Forward Olo Inc. (NYSE: OLO) garnered considerable attention as its...

Continue Reading
CACI International Welcomes New Board Member Scott Morrison

Updated Category News Views 220

Scott C. Morrison Joins CACI International's Board CACI International Inc (NYSE: CACI) has recently announced that Scott C. Morrison has joined its Board of Directors. This strategic appointment is effective immediately and highlights CACI's commitment to enhancing its leadership with experienced professionals. Morrison, recognized for his vast financial expertise, will...

Continue Reading
Frontera Energy's Q2 Report: Key Insights and Figures

Updated Category News Views 235

Frontera Energy Reports Second Quarter 2025 Results Key Financial Highlights: Frontera Energy Corporation (TSX: FEC) has reported significant financial outcomes for the second quarter of 2025. The company recorded a net loss of $455.2 million, primarily due to non-cash impairment charges tied to its interests in various assets. Despite the challenges, total production...

Continue Reading
Investigation Launched for Bank of Montreal Investors' Rights

Updated Category News Views 57

Bank of Montreal Investors Under Review Pomerantz LLP has initiated an investigation focused on potential claims that may impact investors of Bank of Montreal, recognized by its stock symbol BMO (NYSE: BMO). The firm is urging individuals who have invested in the company to come forward and discuss their concerns. With a commitment to protecting investor rights, Pomerantz...

Continue Reading
Hard Rock International and Seminole Gaming's Ocean Initiative

Updated Category News Views 240

Hard Rock International and Seminole Gaming Unite for Sustainability A global effort resulted in the collection of over 6,400 lbs. of waste, engaging more than 1,700 participants from various countries and communities. This initiative illustrates the commitment of Hard Rock International and Seminole Gaming to environmental stewardship through the Global Sound Waves...

Continue Reading